Financial reports
10-K
2023 FY
Annual report
7 Mar 24
10-Q
2023 Q3
Quarterly report
13 Nov 23
10-Q
2023 Q2
Quarterly report
3 Aug 23
10-Q
2023 Q1
Quarterly report
12 May 23
ARS
2022 FY
Annual report to shareholders
27 Apr 23
10-K
2022 FY
Annual report
30 Mar 23
10-Q
2022 Q3
Quarterly report
3 Nov 22
10-Q
2022 Q2
Quarterly report
8 Aug 22
10-Q
2022 Q1
Quarterly report
9 May 22
10-K
2021 FY
Annual report
29 Mar 22
Current reports
8-K
IGM Biosciences Announces Refocusing of Sanofi Collaboration
17 Apr 24
8-K
IGM Biosciences Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
7 Mar 24
8-K
Results of Operations and Financial Condition
8 Jan 24
8-K
IGM Biosciences Announces Strategic Pipeline Prioritization and Cash Runway Extension
8 Dec 23
8-K
IGM Biosciences Announces Third Quarter 2023 Financial Results
13 Nov 23
8-K
Departure of Directors or Certain Officers
3 Oct 23
8-K
IGM Biosciences Announces Second Quarter 2023 Financial Results
3 Aug 23
8-K
Departure of Directors or Certain Officers
27 Jun 23
8-K
Entry into a Material Definitive Agreement
23 Jun 23
8-K
IGM Biosciences Announces Update on IGM-8444 Phase 1 Trial and Future Clinical Development
21 Jun 23
Registration and prospectus
S-8
Registration of securities for employees
7 Mar 24
S-3
Shelf registration
13 Nov 23
D
Exempt offering of security
7 Jul 23
424B5
Prospectus supplement for primary offering
23 Jun 23
FWP
Free writing prospectus
22 Jun 23
424B5
Prospectus supplement for primary offering
22 Jun 23
FWP
Free writing prospectus
21 Jun 23
S-8
Registration of securities for employees
30 Mar 23
S-3
Shelf registration
3 Nov 22
424B3
Prospectus supplement
8 Aug 22
Proxies
PRE 14A
Preliminary proxy
15 Apr 24
DEFA14A
Additional proxy soliciting materials
27 Apr 23
DEF 14A
Definitive proxy
27 Apr 23
DEFA14A
Additional proxy soliciting materials
27 Apr 22
DEF 14A
Definitive proxy
27 Apr 22
DEFA14A
Additional proxy soliciting materials
29 Apr 21
DEF 14A
Definitive proxy
29 Apr 21
PRE 14A
Preliminary proxy
16 Apr 21
DEF 14A
Definitive proxy
6 Jul 20
PRE 14A
Preliminary proxy
23 Jun 20
Other
EFFECT
Notice of effectiveness
28 Nov 23
CORRESP
Correspondence with SEC
15 Nov 23
UPLOAD
Letter from SEC
14 Nov 23
EFFECT
Notice of effectiveness
15 Nov 22
CORRESP
Correspondence with SEC
9 Nov 22
UPLOAD
Letter from SEC
9 Nov 22
EFFECT
Notice of effectiveness
20 Aug 21
EFFECT
Notice of effectiveness
20 Aug 21
CORRESP
Correspondence with SEC
17 Aug 21
CORRESP
Correspondence with SEC
17 Aug 21